1-7 of 7
Gerald P. Linette
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations

Gerald P. Linette, Adham S. Bear, Beatriz M. Carreno
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10): 2017–2024.
https://doi.org/10.1158/1078-0432.CCR-23-1212
Published: 15 May 2024
View article titled, Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations
Open the PDF for Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations in another window
Journal Articles

BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma

Janice M. Mehnert, Tara C. Mitchell, Alexander C. Huang, Tomas S. Aleman, Benjamin J. Kim, Lynn M. Schuchter, Gerald P. Linette, Giorgos C. Karakousis, Sheryl Mitnick, Lydia Giles, Mary Carberry, Noelle Frey, Andrew Kossenkov, Roman Groisberg, Leonel F. Hernandez-Aya, George Ansstas, Ann W. Silk, Sunandana Chandra, Jeffrey A. Sosman, Phyllis A. Gimotty, Rosemarie Mick, Ravi K. Amaravadi
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (6): 1098–1106.
https://doi.org/10.1158/1078-0432.CCR-21-3382
Published: 15 March 2022
View article titled, BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced <em>BRAFV600</em>-mutant Melanoma
Open the PDF for BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced <em>BRAFV600</em>-mutant Melanoma in another window
Includes: Supplementary data
Journal Articles

CAR T-Cell Therapies in Glioblastoma: A First Look

Denis Migliorini, Pierre-Yves Dietrich, Roger Stupp, Gerald P. Linette, Avery D. Posey, Jr, Carl H. June
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (3): 535–540.
https://doi.org/10.1158/1078-0432.CCR-17-2871
Published: 31 January 2018
View article titled, CAR T-Cell Therapies in Glioblastoma: A First Look
Open the PDF for CAR T-Cell Therapies in Glioblastoma: A First Look in another window
Journal Articles

Abstract IA19: Human melanoma neoantigens: Identification and vaccination

Gerald P. Linette
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1_Supplement): IA19.
https://doi.org/10.1158/1557-3265.PMSCLINGEN15-IA19
Published: 03 January 2016
View article titled, Abstract IA19: Human melanoma neoantigens: Identification and vaccination
Journal Articles

Immunodeficient Mouse Strains Display Marked Variability in Growth of Human Melanoma Lung Metastases

Beatriz M. Carreno, Joel R. Garbow, Grant R. Kolar, Erin N. Jackson, John A. Engelbach, Michelle Becker-Hapak, Leonidas N. Carayannopoulos, David Piwnica-Worms, Gerald P. Linette
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (10): 3277–3286.
https://doi.org/10.1158/1078-0432.CCR-08-2502
Published: 18 May 2009
View article titled, Immunodeficient Mouse Strains Display Marked Variability in Growth of Human Melanoma Lung Metastases
Open the PDF for Immunodeficient Mouse Strains Display Marked Variability in Growth of Human Melanoma Lung Metastases in another window
Journal Articles

Immunization Using Autologous Dendritic Cells Pulsed with the Melanoma-Associated Antigen gp100-Derived G280-9V Peptide Elicits CD8+ Immunity

Gerald P. Linette, Dongsheng Zhang, F. Stephen Hodi, Eric P. Jonasch, Simonne Longerich, Christopher P. Stowell, Iain J. Webb, Heather Daley, Robert J. Soiffer, Amy M. Cheung, Sara G. Eapen, Sharon V. Fee, Krista M. Rubin, Arthur J. Sober, Frank G. Haluska
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7692–7699.
https://doi.org/10.1158/1078-0432.CCR-05-1198
Published: 08 November 2005
View article titled, Immunization Using Autologous Dendritic Cells Pulsed with the Melanoma-Associated Antigen gp100-Derived G280-9V Peptide Elicits CD8<sup>+</sup> Immunity
Open the PDF for Immunization Using Autologous Dendritic Cells Pulsed with the Melanoma-Associated Antigen gp100-Derived G280-9V Peptide Elicits CD8<sup>+</sup> Immunity in another window
Journal Articles

Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy

Lynn C. Hartmann, Karen H. Lu, Gerald P. Linette, William A. Cliby, Kimberly R. Kalli, David Gershenson, Robert C. Bast, James Stec, Natalia Iartchouk, David I. Smith, Jeffrey S. Ross, Sebastian Hoersch, Viji Shridhar, James Lillie, Scott H. Kaufmann, Edwin A. Clark, Andrew I. Damokosh
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (6): 2149–2155.
https://doi.org/10.1158/1078-0432.CCR-04-1673
Published: 23 March 2005
View article titled, Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy
Open the PDF for Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy in another window